ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

Print Page
Email Article

Recognizing Chronic Fatigue Syndrome is Key to Improving Outcomes

  [ 35 votes ]   [ Discuss This Article ] • February 13, 2002

By Lynn Eaton, London

Source: BMJ 2002;324:131

The government has finally issued its long awaited report on the management of chronic fatigue syndrome (also known as myalgic encephalomyelitis, or "ME"), after delaying publication earlier this month because several committee members resigned (5 January, p 7).

The report says that health professionals should recognise the condition as a chronic illness and that early recognition is key to improving outcomes.

Speaking at the launch, chief medical officer Professor Liam Donaldson acknowledged that the three years spent drawing up the report had been "enormously difficult, complex, and at some times controversial."

"I've received a large amount of correspondence about this," he said, admitting, "I'm a little surprised we have been able to get such a comprehensive and valuable report."

As the BMJ reported last week, four clinicians and two patients resigned over the final version of the report. The clinicians argued that the psychosocial side of the condition should have had greater emphasis and were concerned that "pacing"where patients limit their activities depending on the day to day severity of the conditionwas included as a form of treatment. Research into the effectiveness of pacing is limited, although the treatment is recommended by many of the patient groups and some doctors.

The patients who resigned objected to the inclusion of graded exercise as a treatment option. Simon Lawrence, coordinator of the 25% ME Group, representing people with severe chronic fatigue syndrome, said he couldn't sign up to its recommendation of cognitive behaviour therapy and graded exercise.

"Many of our patients are severely affected because they have tried these types of treatments and have come out," he said.

Even the name has been controversial, said Professor Donaldson, who said that the condition would now be known as CFS/ME. He said a referral to the National Institute for Clinical Excellence to provide guidance on management and treatment would be considered "in due course."

Despite the controversy, the report was welcomed by Action for ME, one of six groups representing people with the condition.

"It's not the end of the road, but as far as we are concerned it is a breakthrough that the government is recognising the severity of the condition," said the group's chief executive, Chris Clark.

Professor Anthony Pinching, head of pathology at Barts and The London NHS Trust and deputy chairman of the working group, said many GPs were reluctant to diagnose the condition. "If they think it might be CFS/ME, they don't know what to do. It wasn't taught at medical school, and what they have heard about it doesn't encourage them to get involved." He accepted that some patients had been pushed to do too much when they were not physically able. Treatments had to be adapted to individual patients' needs, he said.

Michael Sharpe, senior lecturer in psychological medicine at Edinburgh University and a pioneer of cognitive behaviour therapy for the syndrome, said the report represented an "uneasy compromise" between the consumer's view and the scientific view.

But he added that doctors would not accept pacing as a treatment just because it was recommended in the report. (See p 124.)

The report of the CFS/ME Working Group is available at

Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor® Ultra ATP+, Double Strength

Article Comments

Be the first to comment on this article!

Post a Comment

Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol
The Super Antioxidant for Brain, Joint and Heart Health The Super Antioxidant for Brain, Joint and Heart Health
Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map